Price $40.46 |
Market Cap
10.34B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
4.32
|
P/S
3.31
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
21.4K
|
FCF
-0.2
|
|
Op. Margin
-9.20%
|
Net Margin
-4.20%
|
ROE
-4.70%
|
ROI
14.50%
|
|
ROA
-1.70%
|
EPS Growth
-117.10%
|
Current Ratio
0.8
|
Debt/Equity
78.80%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Aralez Pharmaceuticals Inc (ARLZ) | $0.39 | - | - | 27.8M | Strong Buy |
| Opiant Pharmaceuticals Inc (OPNT) | $14.86 | - | - | 44.2M | Strong Buy |
| Neurometrix Inc (NURO) | $1.33 | - | - | 10M | Strong Buy |
| NeoGenomics, Inc. (NEO) | $14.05 | - | - | 935.2M | Strong Buy |
| China Health Industries Holdin (CHHE) | $0.86 | - | - | 55.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
